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Abstract: In previous studies, we have demonstrated that chronic administration of
systemic glucocorticoids decreases cortical bone mineral density (BMD), cortical bone
volume, bone strength, and induces development of pathologic fractures in asthmatic
patients. We have also demonstrated that glucocorticoid administration appears to be
responsible for the process of cortical bone porosity at both endosteal and intracortical
sites in postmenopausal asthmatic patients. There is a difference of gonadal hormones
between male and female. To investigate the influence of hormonal difference
on glucocorticoid-induced cortical bone porosity, we studied cortical bone volume and
BMD in both male and female patients with asthma in this report.
A total of 99 asthmatic patients (male 26 cases, female 73 cases) were enrolled in
the study. Peripheral quantitative computed tomography (pOCT) was used to measure
cortical BMD and relative cortical volume.
The cortical volume-density relationship appeared to remain constant regardless of
the level of systemic glucocorticoid administration, age or sex, suggesting cortical bone
porosity causes similar and simultaneous decreases in cortical bone volume and density.
In conclusion, glucocorticoid administration appears to be responsible for the process
of cortical bone porosity at both endosteal and intracortical sites despite the gonadal
hormonal differences.
Key words: bronchial asthma. systemic glucocorticoid, cortical bone, cortical porosity,
peripheral quantitative computed tomography
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Introduction
Recently, techniques for measuring bone
mineral density (BMD) have been developed.
Peripheral quantitative computed tomography
(pQCT) measures three-dimensional density,
and separately determines both cortical bone
density and trabecular bone density with a
high level of precisionl -3). pQCT on the radius
is also known to provide an accurate assess-
ment of the general condition of bone4-.).
Other standard densitometric methods, such
as dual energy X-ray densitometor (DXA)
gave little or no information about bone
quality or distribution71 •
Trabecular bone and cortical bone differ
in their remodelling characteristics~ 0), and
structureS). Cortical bone is closely related to
bone strength and stiffness~ 10). Both cortical
bone density7.14l and cortical bone volumeD. 11-14)
are known to influence bone strength.
Using pQCT, previous studies have reported
that aging is associated with a reduction in
cortical bone volume as well as a reduction
in cortical bone densityS-l.. 14-1.). Fujii et al. l3)
demonstrated that a fixed ratio exists be-
tween the radius cortical volume and density
in healthy adult humans regardless of either
age or sex, suggesting that cortical bone po-
rosity causes similar and simultaneous de-
creases in cortical bone volume and density
during the aging processes. In secondary hy-
perparathyoidism, similar findings were ob-
served in uremic patients on maintenance
hemodialysis17l •
Chronic use of systemic glucocorticoids
(GC) is known to lead to progressive bone
loss and the development of pathologic frac-
tures in a correlating manner with the cumu-
lative dose of GClS-2l). Recent our studies have
demonstrated using pQCT that chronic ad-
ministration of systemic glucocorticoids de-
creases cortical BMD, trabecular BMD, and
induces development of pathologic fractures
in asthmatic patients6,22). We have also dem-
onstrated that glucocor-ticoid administration
appears to be responsible for the process of
cortical bone porosity at both endosteal and
intracortical- sites in postmenopausal asth-
matic patients22).
In females, there is an irreversible and sub-
stantial loss of 'bone consequent to the lack
-of estrogen in the 10 year period following
menopause23). Previous reports have detected
perimenopausal bone loss in both trabecular
and cortical bone using pQCT I5). There is a
difference of gonadal hormones between male
and female, and this hormonal difference ap-
pear to influence bone metabolism. In GC-
induced bone loss, however, the relationship
between corticaJ volume and density conCern-
ing cortical bone porosity have to date never
been studied in male patients. To investigate
the influence of hormonal difference on
glucocorticoid-induced cortical bone porosity,
we studied changes in cortical bone volume
and BMD using pQCT in both male and fe-
male patients with asthma undergoing sys-
temic glucocorticoid therapy in the present
study.
Methods
SUBJECTS
Ninety-nine outpatients with asthma (male
26 cases, female 73 cases) were enrolled in
the study. Seventy-three patients were natu-
rally postmenopausal females, and 59 out of
73 patients over 65 years of age had gone
through menopause at least 10 years prior to
the start of the study. Twenty~six patients
were males, including 21 patients over 65
years of age were also inclUded. All patients
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had taken inhaled GC (range: 200 to 800 J1 g/
day of beclomethasone dipropionate ; mean: 3
18 J1 g/day) over a period of 2 to 8 years
(mean: 4.7 years). All patients were devided
to six groups by age and sex (Table 1, 2, 3).
In aged male patients over 65 years, 6 pa-
tients without systemic GC therapy, GC ( - )
group, received less than a 0.5g cumulative
dose of prednisolone, and 15 patients with
systemic GC therapy, GC (+) group, received
more than a 109 cumulative dose of pred-
nisolone (mean: equivalent of 37.7g of pred-
nisolone) over a prolonged period (mean: 9.7
years) (Table 1).
Table 1. Aged Male Patient Characteristics
Divided by Cumulative Dose of Gluco-
corticoid Use.
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age, height, weight, or body mass index
(BM!) between the two groups (Table 1). In
aged female patients over 65 years, 22 pa-
tients without systemic GC therapy, GC ( - )
group, received less than a 0.5g cumulative
dose of prednisolone, and 37 patients with
systemic GC therapy, GC (+) group, re-
ceived more than a 109 cumulative dose of
prednisolone (mean: equivalent of 21.5g of
prednisolone) over a prolonged period (mean:
7.7 years). There were no significant differ-
ences in age, age at' menopause, years since
menopause (YSM), height, weight, or BMI be-
tween groups (Table 2).
In patients under 65 years without systemic
GC therapy, 5 male patients and 14 female
patients were included (Table 3).
Ago <.-sl
_(em)
W_(kg)
... 0CgIm')
c.m..........."' ............<.)
12.4%3.4
158.9~6.7
51.9:1:7.9
20.5:1:2.5
0.03:1:0.07
72.3:t4.1
163.2:1:6.1
57.0:i:5.5
21.4:1:1.7
37.7:1:20.1
ttest
N.S.
N.S.
N.S.
N.S.
peO.Ol
Patients who had taken medication that af-
fects bone metabolism or patients with medi-
cal conditions that affect bone metabolism
were excluded from the study. No patient had
undergone treatment for osteoporosis, such as
hormone replacement therapy. No patient had
alcohol dependency, and no patient was a
smoker. A history was taken, and a physical
examination was performed on all patients.
Duration, daily, dose, and lifetime cumulative
dose of GC were calculated from medical
records and a patient's personal records. The
dose of GC is expressed in equivalent grams
of prednisolone.
METHODS
pQCT was performed on the non-dominant
radius using a Stratec XCT 960 (Nishimoto,
Tokyo, Japan), as described previously~ 24) •
Briefly, the mid-radial 20% site was used to
calculate cortical BMD. Constant threshold
levels were used for all subjects (0.5mg/en!
for total bone and 0.93mg/cnf for cortical
bone) ..
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Relationship between cortical density
and relative cortical volume in 6 aged
(~65years) male asthmatic patients
without systemic glucocorticoid ther-
apy. A correlation (p<0.05) of rb
0.373 was obtained.
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Fig. 1.
Total and cortical area were estimated
based on voxel number at the mid-radial 20%
site region, and relative cortical volume, de-
fined as cortical volume divided by the total
bone volume, was calculated by dividing cor-
tical area with total area, as described
previously l~ 22, 25).
Results
Statistical analysis
Student's t test and other statistical analy-
ses were performed using the software pack-
age, StatView (Abacus Concepts, Berkeley,
CA, USA). A p value < 0.05 was considered
to be significant.
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Fig. 2. Relationship between cortical density
and relative cortical volume in 15
aged (~65years) male asthmatic pa-
tients with systemic glucocorticoid
therapy who received more than a
109 cumulative dose of predonisolone.
A highly significant correlation (p<
0.000 of r2 =0.919 was obtained.
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Discussion
A significant correlation between relative
cortical volume and cortical BMD showing a
rectilinear relationship was observed in the
aged (~65years) male GC ( - ) group (p<
0.05, r2 = 0.373) (Figure 0, the aged (~65
years) male GC (+) group (p<O.OOOl, r2 =
0.919) (Figure 2) , the aged (~65years) fe-
male GC (- ) group (p<O.OOOl, r2 =0.770)
(Figure 3), the aged (~65years) male GC
(+) group (p<O.OOOl, r 2 =0.767) (Figure 4),
the not aged «65years) male GC ( - ) group
(p<O.OOOl, r2 =0.994) (Figure 5), and the
not aged «65years) female GC ( - ) group
(p<O.OOOl, r2=0.808) (Figure 6).
No significant differences in the cortical
volume-density slopes were observed among
all groups of patients.
Aging is reportedly associated with a re-
duction in cortical volume due to a widening
of the marrow cavity as well as a reduction
in cortical density8,1~15,16). Using pQCT, Fujii
et al. previously reported that the radius cor-
tical volume and density are rectilinearly
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Fig. 3. Relationship between cortical density
and relative cortical volume in 22
aged ( ;;;;; 65years) female asthmatic
. patients without systemic glucoco-
rticoid therapy. A highly significant
correlation (p<O.OOO of r2 = 0.770
was obtained.
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Fig. 5. Relationship between cortical density
and relative cortical volume in5 not
aged «65years) male asthmatic pa-
tients without systemic glucocorti-
coid therapy. A highly significant
correlation (p<O.OOl) of r2 = 0.994
was obtained.
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Fig. 4. Relationship between cortical density
and relative cortical volume in 37
aged (;;;;; 65years) female asthmatic
patients with systemic glucocorticoid
therapy who received more than a
109 cumulative dose of predonisolone.
A highly significant correlation (p<
0.000 of r2 = 0.767 was obtained.
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Fig. 6. Relationship between cortical density
and relative cortical volume in 14 not
aged «65years) female asthmatic
patients without systemic glucoco-
rticoid therapy. A highly significant
correlation (p<O.OOl) of r2 = 0.808
was obtained.
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correlated in the aging processes of healthy
adult humansl 3). Similar findings have also
been reported m secondary hyperparath-
yoidism in uremic patients on maintenance
hemodialysisl1). In the previous paper, we have
also demonstrated that the radius cortical
bone volume and density are rectilinearly cor-
related in postmenopasal asthmatic patients,
regardless of the level of systemic GC ther-
apy, and the two cortical volume-density
slopes in patients with or without continu-
ous systemic GC therapy appear largely
identical22J •
In the present study, we confirmed these
cortical volume-density relationships in post-
menopausal patients regardless of the level of
systemic GC therapy, and indicated similar
relationships in male patients irrespective of
the level of systemic GC therapy. These
slopes were roughly identical to the slopes
for not aged patients without systemic GC
therapy in this study. These slopes were also
roughly identical to the slopes for healthy
adult humans in the previous report13J • In
view of the highly significant correlation be-
tween relative cortical volume and density in
the radial cortex, a single process of GC-
induced cortical bone resorption, or so-called
cortical porosity, appears to be responsible at
both the endosteal and intracortical sites for
causing similar and simultaneous decreases in
cortical bone volume and density despite the
gonadal hormonal differences, as in the aging
processes13J , or in secondary hyperparath-
yoidism in uremic patients on maintenance
hemodialysis17J •
In conclusion, glucocorticoid administration
appears to be responsible for the process of
cortical bone porosity at both endosteal and
intracortical sites despite the gonadal hormo-
nal differences.
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気管支唱息症例における皮質骨海綿化
柘野浩史D.中井睦郎2),岡本 誠1),原田誠之l),
高田真吾l),御船尚志1),光延文裕D,芦田耕三O,
保崎泰弘D,穐山恒堆2),辻 孝夫3),谷崎勝朗1)
D岡山大学医学部三朝分院内科, 2)同放射線室,
3)医学部第-内科
【目的】これまでに我々は,気管支鳴息症例にお
いて経口ステロイドによる皮質骨骨密度,容積の
減少が骨折に関与する新知見を報告し,閉経後女
性では皮質骨骨密度一容積の減少はステロイド投
与量にかかわらず一定であることを報告してきた｡
この皮質骨骨密度一容積の関係において性差によ
60
る違いを検討するために,男性,女性患者の両方
について検討を行った｡ 【方法】対象はステロイ
ド依存性噂息99例 (男性26例,女性73例)｡性別,
年齢,経口ステロイド積算総投与量により6群に
分類した｡椎体圧迫骨折はⅩ線側面像にて評価
し,皮質骨容積比および皮質骨骨密度はpQCT
(StratecXCT960)を用いて測定 した｡それぞれ
の群の皮質骨骨密度一容積比の関係を算出し比較
検定をおこなった｡ 【結果】それぞれの群の皮質
骨の骨密度と容積比は有意に相関した｡それぞれ
の群の皮質骨骨密度一容積比の傾きは,いずれも
有意差を認めなかった｡ 【結論】気管支嶋息症例
におけるステロイド投与による皮質骨の骨密度と
容積の減少は,性別にかかわらずほぼ一定で,皮
質骨は内側と外側において同様に海綿化してゆく
と考えられた｡
